Natco Pharma Ltd
NSE:NATCOPHARM

Watchlist Manager
Natco Pharma Ltd Logo
Natco Pharma Ltd
NSE:NATCOPHARM
Watchlist
Price: 1 376.55 INR 0.7% Market Closed
Market Cap: 246.6B INR
Have any thoughts about
Natco Pharma Ltd?
Write Note

Gross Margin
Natco Pharma Ltd

83.4%
Current
77%
Average
48.3%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
83.4%
=
Gross Profit
35.2B
/
Revenue
42.2B

Gross Margin Across Competitors

Country IN
Market Cap 246.4B INR
Gross Margin
83%
Country JP
Market Cap 776 550.9T JPY
Gross Margin
-3%
Country US
Market Cap 758.2B USD
Gross Margin
81%
Country UK
Market Cap 440.4B GBP
Gross Margin
56%
Country DK
Market Cap 3.3T DKK
Gross Margin
85%
Country US
Market Cap 367.6B USD
Gross Margin
69%
Country US
Market Cap 250.1B USD
Gross Margin
77%
Country CH
Market Cap 208.5B CHF
Gross Margin
73%
Country CH
Market Cap 181.2B CHF
Gross Margin
75%
Country UK
Market Cap 159.6B GBP
Gross Margin
82%
Country IE
Market Cap 155B USD
Gross Margin
68%

Profitability Report

View the profitability report to see the full profitability analysis for Natco Pharma Ltd.

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
83.4%
=
Gross Profit
35.2B
/
Revenue
42.2B
What is the Gross Margin of Natco Pharma Ltd?

Based on Natco Pharma Ltd's most recent financial statements, the company has Gross Margin of 83.4%.